News
Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director
Lindus Therapeutics, a next-generation drug development company advancing a portfolio of in-licensed assets, has announced the appointment of Dr. Gillian Cannon to its board of directors as a non-executive director.
.jpeg)
Why working with a university isn't always best for DTx start-ups
Our Co-Founder Michael explores the best options for DTx startups looking to start generating clinical evidence and why it might not always be best to work with academic institutions.
Why I Joined Lindus Health - Emma Ogburn PhD, VP Clinical Operations
To work on innovative trials and accelerate access to treatments. To tackle disparities in research accessibility. To use technology to accelerate studies and work with a motivated team. Hear more from our VP of Clinical Operations, Emma Ogburn PhD, on why she joined Lindus Health.
New Study from Lindus Health Finds Patients are More Likely to Join a Clinical Trial with Telehealth Care
Discover key findings from on clinical trial participation in our most recent consumer survey.
New Pharmanovia Study Results Reveal Chloral Hydrate Noticeably Improves Severe Insomnia Within Two Weeks
Pharmanovia's chloral hydrate elicited improvements in patients with severe insomnia. Learn more about our study together here.
Aptar Digital Health Announces Asthma Clinical Study with Guy’s and St Thomas’ NHS Foundation Trust
Introducing our study with Aptar Digital Health.
Lindus Health Announces the Completion of Two Clinical Trials for Woebot Health’s Digital Application for Depression and Anxiety Symptoms
Sharing recent developments from our recent trials with Woebot Health.
PILA PHARMA INKS AGREEMENT WITH LINDUS HEALTH ABOUT NEXT CLINICAL TRIAL WITH SAFETY AND OBESITY READOUTS
Announcing our Phase 2a clinical trial with PILA PHARMA to assess the tolerability, safety, and efficacy of XEN-D0501 in patients with type II diabetes and obesity.
Lindus Health and Aktiia to launch observational clinical trial for Aktiia’s Optical Blood Pressure Monitoring Device
We're pleased to announce the launch of our 7,500-participant trial with Aktiia!
Lindus Health and Tasso Establish Collaboration to Streamline Clinical Trials Through Remote Blood Collection
Lindus Health has adopted Tasso's remote blood collection technology to promote efficiency and patient-centricity in clinical trials.
Prebiotic Fibre Supplement Significantly Reduces Risk of Developing Type 2 Diabetes, UK Study Finds
We're excited to share the positive results from our study with Myota in reducing risk of developing Type 2 diabetes.